Objectives This meta-analysis of randomized controlled trials (RCTs) investigated the
usefulness of mesenchymal stromal cells (MSCs) to treat patients with COVID-19. Methods …

Background aims Evidence regarding the extent that mesenchymal stromal cells (MSCs)
may improve clinical outcomes in patients with coronavirus disease 2019 (COVID-19) has …

Background: Coronavirus disease 2019 (COVID-19) is an infectious respiratory disease
prevalent worldwide with a high mortality rate, and there is currently no specific medicine to …

Background The present study aims to better understand the efficacy and safety of
mesenchymal stromal cells (MSCs) in treating severe/critical patients with COVID-19 …

Abstract Background Mesenchymal stromal cells (MSCs) may reduce mortality in patients
with COVID-19; however, early evidence is based on few studies with marked interstudy …

The objective of this study was to assess whether mesenchymal stem cells (MSCs) therapy
could offer survival advantages for patients with novel coronavirus disease 2019 (COVID …

Background The coronavirus disease 2019 (COVID-19) has become a serious public health
issue. In COVID-19 patients, the elevated levels of inflammatory cytokines lead to the …

Background Mesenchymal stem/stromal cells (MSCs) and their secreted products are a
promising therapy for COVID-19 given their immunomodulatory and tissue repair …

Abstract Background Coronavirus disease‐19 (COVID‐19) is a zoonotic disease that has
become a global pandemic. The fast evolution of the COVID‐19 pandemic and persist …

Abstract Coronavirus disease 2019 (COVID-19) is a highly infectious epidemic disease that
has seriously affected human health worldwide. To date, however, there is still no definitive …